Old Web
English
Sign In
Acemap
>
authorDetail
>
Gary Hogge
Gary Hogge
Élan
Natalizumab
Medicine
Immunology
Diabetes mellitus
Physical therapy
4
Papers
800
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Common Measures of Quality of Life in CD patients: P-64
2012
Inflammatory Bowel Diseases
Sunanda V. Kane
Arpita Nag
Lori Taylor
Gary Hogge
Jean-Frederic Colombel
James D. Lewis
David T. Rubin
Remo Panaccione
Show All
Source
Cite
Save
Citations (0)
TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Crohnʼs Disease Severity: P-63
2012
Inflammatory Bowel Diseases
James D. Lewis
Arpita Nag
Lori Taylor
Gary Hogge
Jean-Frederic Colombel
Sunanda V. Kane
Remo Panaccione
David T. Rubin
Show All
Source
Cite
Save
Citations (0)
TOUCH® PRO Study: The Impact of Natalizumab on Utilization of Healthcare Resources by the Patients and Their Associated Treatment Satisfaction: P-65
2012
Inflammatory Bowel Diseases
David T. Rubin
Arpita Nag
Lori Taylor
Gary Hogge
Sunanda V. Kane
James D. Lewis
Remo Panaccione
Jean-Frederic Colombel
Show All
Source
Cite
Save
Citations (0)
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
2005
The New England Journal of Medicine
William J. Sandborn
Jean-Frederic Colombel
Roberts Enns
Brian G. Feagan
Stephen B. Hanauer
Ian C. Lawrance
Remo Panaccione
Martin Sanders
Stefan Schreiber
Stephan R. Targan
Sander J. H. van Deventer
Ronald Goldblum
Darrin Despain
Gary Hogge
Paul Rutgeerts
Show All
Source
Cite
Save
Citations (800)
1